| Accession Number | 0001628280-25-058843 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 29, 2025 |
| Document Date | Dec 26, 2025 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CRO & Pres. Life Sciences | Common Stock | โ | Dec 26, 2025 | Sale | 74 | $196.08 | $14,509.92 | 16,506 | Direct | โ | View Details |